Please sign in to follow a disease.
Eye surgery trial to prevent blindness in stickler syndrome pulled before start
NCT ID NCT04465188
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if a surgical procedure called scleral buckling could prevent retinal detachment in people with Stickler syndrome, a genetic condition that raises the risk of vision loss. The plan was to treat one eye in patients aged 5 to 35 who had already lost vision in the other eye. However, the trial was withdrawn before enrolling any participants, so no conclusions can be drawn.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- scleral buckle surgical procedure
- What this could lead to
- If it had worked, this could have pointed toward a way to prevent retinal detachment and vision loss in people with Stickler syndrome.
- What could go wrong
- The trial was withdrawn before it started, so no results are available. Even if it had run, it was a small early-phase study, and surgery carries risks like infection or bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Expected to start
-
Jun 2023
An estimate. Start dates often move.
- Expected to finish
-
Jun 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
5 to 35 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Genetically confirmed Stickler Syndrome * Aged 5 to 35 * Recent retinal detachment in the non-study eye (\<24 months) * Signed informed consent to participate in the study; For the minors, information and consent of the holders of parental authority * Sufficient patient cooperation to perform a complete ophthalmologic examination including a dilated fundus examination * Patients affiliated with social security or CMU (profit or being entitled) Exclusion Criteria: * • Any type of previous prevention (laser, cryotherapy, scleral buckle) for the study eye * Subclinical retinal rhegmatogenous detachment in the study eye. * Any other ocular disease unrelated to Stickler syndrome significantly affecting visual acuity (ETDRS BCVA\<20/400). * Contraindications to general anesthesia * Posterior vitreoretinal traction on optical coherence tomography * Pregnant or breastfeeding women * Any patient presenting an intraocular pressure during the inclusion visit (M-3) greater than 30 mm Hg * Hypersensitivity to povidone iodine, iodine or any of the excipients of the specialty used * Hypersensitivity to acetazolamide or any of the excipients of the specialty used * Severe hepatic, renal or adrenal insufficiency * Sulfonamide intolerance * History of renal colic * Pre-existing plasma hyperosmolarity * Predominantly intracellular dehydration * Hypersensitivity to dexamethasone or any of the excipients of the specialty used * Hypersensitivity to oxytetracycline or to any of the excipients of Sterdex * Treatment with retinoids * Hypersensitivity to the active substances or to any of the excipients of Chibrocadron® * Personal or family history of glaucoma(Open angle primary glaucoma only) * Intraoperative detection of one or more of the above-mentioned non-inclusion criteria
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Stickler syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Cochin
Paris, 75014, France